The BMJ: Leading Medical Research, News, Education, Opinion
High impact medical journal. Champion of better research, clinical practice & healthcare policy since 1840. For GPs, hospital doctors, educators, policymakers.
PRISMA 2020 explanation and elaboration: updated guidance and …
2021年3月29日 · The methods and results of systematic reviews should be reported in sufficient detail to allow users to assess the trustworthiness and applicability of the review findings. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement was developed to facilitate transparent and complete reporting of systematic reviews and has been updated (to PRISMA 2020) to reflect ...
The PRISMA 2020 statement: an updated guideline for reporting ...
2021年3月29日 · The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement ...
Effectiveness of public health measures in reducing the ... - The BMJ
2021年11月18日 · Objective To review the evidence on the effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality. Design Systematic review and meta-analysis. Data sources Medline, Embase, CINAHL, Biosis, Joanna Briggs, Global Health, and World Health Organization COVID-19 database (preprints). Eligibility criteria for study selection ...
Therapeutic advances in rheumatoid arthritis | The BMJ
2024年1月17日 · Rheumatoid arthritis (RA) is one of the most common immune mediated inflammatory diseases. People with rheumatoid arthritis present with pain, swelling, and stiffness that typically affects symmetrically distributed small and large joints. Without effective treatment, significant joint damage, disability, and work loss develop, owing to chronic inflammation of the joint lining (synovium). Over ...
Quality improvement into practice - The BMJ
2020年3月31日 · Box 1 Definitions of quality improvement. Improvement in patient outcomes, system performance, and professional development that results from a combined, multidisciplinary approach in how change is delivered.3 The delivery of healthcare with improved outcomes and lower cost through continuous redesigning of work processes and systems.4 Using a systematic change method and strategies to improve ...
Advances in management of heart failure | The BMJ
2024年4月10日 · Survival. Survival following a diagnosis of heart failure is poor and is highly influenced by age. In the UK, survival approaches 80% at five years for people aged 45-64 but is closer to 20% at five years for those aged ≥85.7 Fortunately, survival rates have improved since 2000, particularly among younger patients.7 Although overall survival is an important outcome, it reflects the combined ...
Covid-19: Two rare vaccine side effects detected in large ... - The BMJ
2024年2月26日 · The largest vaccine safety study to date has identified two new, but very rare, side effects associated with covid-19 vaccines—transverse myelitis and acute disseminated encephalomyelitis. The Global Vaccine Data Network cohort study included 99 million vaccinated people from 10 sites across eight countries. Researchers compared the observed with expected rate for 13 neurological, blood, and ...
Advances in the management of idiopathic pulmonary fibrosis and ...
2022年6月29日 · Similarly to idiopathic pulmonary fibrosis (IPF), other interstitial lung diseases can develop progressive pulmonary fibrosis (PPF) characterized by declining lung function, a poor response to immunomodulatory therapies, and early mortality. The pathophysiology of disordered lung repair involves common downstream pathways that lead to pulmonary fibrosis in both IPF and PPF. The antifibrotic ...
Management of pneumonia in critically ill patients | The BMJ
Severe pneumonia is associated with high mortality (short and long term), as well as pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of adequate antimicrobial treatment for severe pneumonia are crucial in improving survival among critically ill patients. Identifying the underlying causative pathogen is also critical for antimicrobial stewardship. However ...